|
|
||||||||||||||
|
|
|||||||||||||||
Correspondence to:
Correspondence to:
Professor Seth Love
Department of Neuropathology, University of Bristol Institute of Clinical Neurosciences, Clinical Science at North Bristol, Frenchay Hospital, Bristol BS16 1LE, UK; seth.love@bris.ac.uk
Keywords: Alzheimers disease; cerebrovascular disease; dementia; neuropathological investigation; Parkinsons disease
| The first 150 words of the full text of this article appear below. |
Dementia is among the most common and disabling of diseases and places a huge burden on carers and families as well as on social and medical services. Its prevalence rises from about 1.4% of adults aged between 6570 years to 23.6% of those over 85. The number of patients with dementia is predicted to increase steeply as the proportion of people surviving well in to old age continues to rise. The annual economic cost is estimated at £7 billion per annum in the UK and over $100 billion in the USA.
Accurate diagnosis of most diseases that cause dementia depends on post-mortem neuropathological examination. In this review, I shall cover some of the practical issues involved in the post-mortem investigation of dementia and describe the principal abnormalities in the more common diseases that are responsible. This is not an exhaustive review of the neuropathology of dementia, which is well covered
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |